Autolus Therapeutics Ltd reported $27.96M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 148M 4.86B Sep/2025
Autolus Therapeutics Ltd USD 27.96M 1.58M Jun/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Novartis USD 3.31B 134M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Silence Therapeutics USD 5.6M 312K Sep/2024